Now, new clinical trial results suggest that an oral form of this medication may be coming soon—and the results so far are ...

Are weight loss shots like Ozempic and Wegovy safe long-term? It’s complicated. Some early studies suggest thyroid concerns ...

It looks likely we'll see oral GLP-1 drugs on the market by next year, with pharmaceutical company Eli Lilly reporting ...

When it comes to compounded Ozempic and other semaglutides, Dr. Goulden adds that they are not identical to their ...

Past research has found that Ozempic may have more health beyond weight loss and weight management. Now, three new studies ...

Novo Nordisk (NVO) said Wednesday it will cut costs as it faces increasing competition from Eli Lilly (LLY) and generic versions of its obesity drug Wegovy, with slower growth expected for its ...

Muscle and strength loss in human aging, also known as sarcopenia, can result in trouble with balance and walking, according to the Cleveland Clinic. It’s a condition often linked to obesity, ...

Linda Yaccarino, the former CEO of the Elon Musk-owned social media platform X, has a new leadership gig in the weight loss space.

Novo Nordisk’s challenges from both a pharmaceutical giant in Lilly and the low-cost competition from compounded drugs ...

A big wave of criticism and backlash has erupted from the LA Lakers fans after a TV show seemed to question if Dallas ...

After Mikayla Nogueira unveiled her 60-pound weight loss transformation, the TikToker cleared the air on how she accomplished ...

Novo Nordisk has named Maziar Mike Doustdar, currently the company’s EVP of international operations, as the new CEO.